These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 16470854)
1. Results of longterm hospital based cytological screening in asymptomatic women. Misra JS; Singh U Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854 [TBL] [Abstract][Full Text] [Related]
2. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening. Misra JS; Gupta HP; Das V Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174 [TBL] [Abstract][Full Text] [Related]
3. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Sardana S; Sodhani P; Agarwal SS; Sehgal A; Roy M; Singh V; Bhatnagar P; Murthy NS Acta Cytol; 1994; 38(5):693-7. PubMed ID: 8091899 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of cancer of the cervix: global and national perspective. Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of gynecologic infections among Indian women. Singh V; Sehgal A; Satyanarayana L; Gupta MM; Parashari A; Chattopadhya D Obstet Gynecol; 1995 Feb; 85(2):215-9. PubMed ID: 7824233 [TBL] [Abstract][Full Text] [Related]
6. Results of clinically downstaging cervical cancer in a cytological screening programme. Misra JS; Das K; Chandrawati Diagn Cytopathol; 1998 Nov; 19(5):344-8. PubMed ID: 9812227 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of cervical smears at King Hussein Medical Centre, Jordan, over three and a half years. Malkawi SR; Abu Hazeem RM; Hajjat BM; Hajjiri FK East Mediterr Health J; 2004; 10(4-5):676-9. PubMed ID: 16335662 [TBL] [Abstract][Full Text] [Related]
10. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515 [TBL] [Abstract][Full Text] [Related]
11. Selective cervical cytology screening: discriminant analysis approach. Juneja A; Murthy NS; Sharma S; Shukla DK; Roy M; Das DK Neoplasma; 1993; 40(6):401-4. PubMed ID: 8289972 [TBL] [Abstract][Full Text] [Related]
12. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach. Misra JS; Srivastava AN; Gupta HP Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440 [TBL] [Abstract][Full Text] [Related]
13. Comparison of risk factors, severity, and treatment of women with genital HPV. Kenney JW Cancer Nurs; 1994 Aug; 17(4):308-17. PubMed ID: 7954378 [TBL] [Abstract][Full Text] [Related]
14. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX; J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827 [TBL] [Abstract][Full Text] [Related]
15. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study. Wikström I; Stenvall H; Wilander E Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903 [No Abstract] [Full Text] [Related]
16. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Donders GG; Gabrovska M; Bellen G; Van Keirsbilck J; Van Den Bosch T; Riphagen I; Verjans M Arch Gynecol Obstet; 2008 Apr; 277(4):291-8. PubMed ID: 17965870 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836 [TBL] [Abstract][Full Text] [Related]
18. Risk-factors and strategies for control of carcinoma cervix in India: hospital based cytological screening experience of 35 years. Misra JS; Srivastava S; Singh U; Srivastava AN Indian J Cancer; 2009; 46(2):155-9. PubMed ID: 19346651 [TBL] [Abstract][Full Text] [Related]
19. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828 [TBL] [Abstract][Full Text] [Related]
20. Herpes genitalis in women attending Planned Parenthood of New York City. Wolinska WH; Melamed MR Acta Cytol; 1970 May; 14(5):239-42. PubMed ID: 4327426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]